IDCRC Newsletter: January 2022

IDCRC Profile: Linda McNeil, MA, PMP
Associate Director, Science Facilitation, FHI 360

"While new to the Vaccine & Treatment Evaluation Unit (VTEU) structure, the experience gained from the years of managing domestic and international, multi-center, Phase I, II and III investigational new drug studies, leading monitoring visits to international research sites to ensure compliance with good clinical practices, conducting training workshops internationally on clinical research topics, and contributing to the expansion and global decentralization of FHI 360’s clinical research management responsibilities, have provided the skills and resources essential to the success of the IDCRC award.”

Manual of Procedures Sections

View approved IDCRC Manual of Procedures (MOP) sections which describe structure, operating policies, roles and responsibilities of entities and individuals within the unit/consortium:

Secondary Research Use of Specimens and/or Data

VIEW ALL SECTIONS

News

Mix-and-Match Trial Finds Additional Dose of COVID-19 Vaccine Safe, Immunogenic

News Released January 26, 2022

In adults who had previously received a full regimen of any of three COVID-19 vaccines granted Emergency Use Authorization (EUA) or approved by the Food and Drug Administration (FDA), an additional booster dose of any of these vaccines was safe and prompted an immune response, according to preliminary clinical trial results reported in The New England Journal of Medicine. The findings served as the basis for recommendations by the FDA and the Centers for Disease Control and Prevention in late fall 2021 to permit mix-and-match COVID-19 booster vaccinations in the United States.

READ NIH RELEASE

READ IDCRC RELEASE

Publications

NOTE: Please include the following citation in any publications resulting from direct or indirect IDCRC support:

"Supported by the Infectious Diseases Clinical Research Consortium through the National Institute for Allergy and Infectious Diseases of the National Institutes of Health, under award number UM1AI148684. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."

View recent publications below:

Training

Mentee Profile: Christine Akamine, MD
Assistant Professor, Baylor College of Medicine

Dr. Akamine's research focus is vaccinology and COVID-19 – specifically the clinical and virologic characteristics of patients with prolonged SARS-CoV-2 nucleic acid detection.

VIEW PROFILE

IDCRC TRAINING

Job Postings

Chief, Respiratory Diseases Branch, NIAID
The NIAID is seeking an exceptional and visionary leader to be chief of the Respiratory Diseases Branch within the Division of Microbiology and Infectious Diseases (DMID). The chief directs and manages a complex scientific program that stimulates basic, translational, and clinical research and advances product development for respiratory infectious diseases of national and international prominence.
Faculty Position - Children's Center for Immunity and Applied Genomics (CIAG)
The Center for Immunity and Applied Genomics (CIAG), a joint entity within Children’s Healthcare of Atlanta and Emory University School of Medicine, invites applications for a tenure eligible position at the Assistant or Associate Professor level, in the broad area of Clinical Genomics (MD and/or PhD required).
Postdoctoral Fellow - HIV/SIV persistence and cure – Chahroudi Lab
The Chahroudi laboratory in the Department of Pediatrics at the Emory University School of Medicine is seeking a highly motivated Postdoctoral Research Fellow to lead an NIH-funded project investigating simian immunodeficiency virus persistence in rhesus macaques. The goal of this work is to investigate HIV/SIV cure strategies to reduce the persistent viral reservoir in the setting of postnatal breast milk transmission in an infant nonhuman primate model.
Visit the IDSA Career Center to browse over 200 ID/HIV Medicine job postings.

Funding Opportunities

Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine – Due February 4
The purpose of this NOSI is to continue to foster new and innovative scientific endeavors in all areas defined in the Strategic Plan for the Development of a Universal Influenza Vaccine.
Strengthening Health Care Infection Prevention & Control (IPC) & Improving Patient Safety in the U.S. – Due February 11
There is a need to strengthen health care IPC practices, inform IPC recommendations, improve how healthcare personnel IPC competencies are assessed, and develop evidence-based approaches to IPC training and education.
Notice of Intent to Publish Funding Opportunity Announcements for the RADx®-UP Initiative (Phase III) – Due March 7
The purpose of this NOSI is to explore novel interventions to increase access to and uptake of rapid SARS-CoV-2 testing (e.g., rapid antigen testing) in an environment of widespread vaccine availability; the social, ethical, and behavioral implications associated with testing; and specific strategies for scalable and sustainable testing programs to enable safe in-person school instruction.
Johnson & Johnson QuickFire Challenge: Improving Detection of Neurotoxicity in Immunotherapies – Due March 18
J&J is seeking methods and technologies aiming to optimize patient care for immunotherapies within the hematologic malignancy space by enabling the early detection of neurotoxic events. Of particular interest are technologies aiming to identify clinical manifestations to predict acute toxicities, including movement and neurocognitive disorders.
Notice of Special Interest (NOSI): Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus – Due March 31
The purpose of this FOA is to highlight the urgent need for continued research on the impacts of SARS-CoV-2, the coronavirus that causes COVID-19.